From C-Suite to VC: Lessons from the Biotech Trenches

3:00 PM - 4:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 252AB
This panel of top-tier biotech CEOs turned VC investors and advisors will discuss their outlook on the financing market, and share key lessons as to how they grew and built their companies to multi-billion dollar valuations. The panel features former CEOs and C-level executives from some of the industry's largest, most prominent biotechs, who have moved to VC.
KKH Advisors
Board Chair
Ventyx, ADARx, and ImmPACT Bio
Executive Advisor
Sofinnova Investments
Venture Partner
Frazier Life Sciences
Senior Scientific Fellow, Broad Institute of MIT and Harvard; Board Member
Eli Lilly